Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer

This publication has 38 references indexed in Scilit:

• Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer
  Annals of Surgical Oncology, 2004
• The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection
  Annals of Surgery, 2004
• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma
  Cancer, 2003
• Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy
  European Journal of Surgical Oncology, 2003
• The decline in cancer mortality in the European Union, 1988–1996
  European Journal Of Cancer, 2000
• Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
  The Lancet, 1997
• Volume measurement in lymphoedema treatment: examination of formulae
  European Journal of Cancer Care, 1995
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation
  Breast Cancer Research and Treatment, 1992